# Management Review Record – MAZA Shield v1.0
**Product:** MAZA Shield – Casino Risk Intelligence Platform  
**Version:** 1.0  
**Review Date:** April 28, 2026  
**Prepared by:** Laura (MAZALab)

## 1. Purpose

This Management Review Record (MRR) documents top management’s **systematic evaluation** of the suitability, adequacy, and effectiveness of MAZALab’s quality management system elements **as applied to MAZA Shield v1.0**, in alignment with **ISO 13485:2016** management review expectations (Clause 5.6) and MAZALab’s FDA QMSR–aligned governance posture.

The review confirms that **policy, planning, risk management, design controls, verification and validation posture, and release readiness** for MAZA Shield v1.0 remain coherent with organizational objectives and regulatory discipline, and that **resource adequacy**, **corrective/preventive interfaces**, and **improvement opportunities** are identified where warranted.

This record **does not replace** underlying controlled documents or evidence repositories; it **summarizes** management conclusions and directs follow-up through explicit decisions and action items.

## 2. Review Scope

| Dimension | Boundaries |
|-----------|------------|
| **Product baseline** | MAZA Shield v1.0 — software-only Casino Risk Intelligence offering (Mother Brain core, assessment pipeline, governance audit subsystem, REST API surface, multilingual Gaming Demo, presenter tooling) per **DP-MAZA-Shield-v1.0** |
| **Quality system envelope** | Design and development planning; design inputs/outputs; risk management; verification and validation planning; design review; release authorization; document registry — as reflected in artifacts listed in **QMSR-Master-Index-MAZA-Shield-v1.0** |
| **Period / baseline** | Review directed at v1.0 controlled baselines with effective dates on or before April 28, 2026, unless otherwise noted in Section 3 |
| **Out of scope** | Operator-specific IQ/OQ in production environments; statutory AML/SAR filing obligations retained by customers; hardware appliance certification |

Management acknowledges that review intervals shall recur per MAZALab procedure and whenever substantial changes affect safety, performance, or regulatory posture.

## 3. Inputs Reviewed

The following **controlled artifacts** and summaries were available to management as inputs to this review:

| Input ID | Title | Path | Role in review |
|----------|-------|------|----------------|
| **DP-MAZA-Shield-v1.0** | Design and Development Plan | `docs/qmsr-iso13485/plans/DP-MAZA-Shield-v1.0.md` | Scope, milestones, design-control sequencing |
| **DID-MAZA-Shield-v1.0** | Design Input Document | `docs/qmsr-iso13485/plans/DID-MAZA-Shield-v1.0.md` | **UN-xxx** / **SR-xxx** requirements baseline |
| **DOS-MAZA-Shield-v1.0** | Design Output Specification | `docs/qmsr-iso13485/records/design-outputs/DOS-MAZA-Shield-v1.0.md` | Realization vs inputs |
| **DR-MAZA-001** | Design Review Record (Design Input Review) | `docs/qmsr-iso13485/records/design-reviews/DR-MAZA-Shield-v1.0.md` | Input completeness and coherence disposition |
| **RMF-MAZA-Shield-v1.0** | Risk Management File | `docs/qmsr-iso13485/records/risk-management/RMF-MAZA-Shield-v1.0.md` | Hazards, controls, residual risk |
| **Risk-Management-Report-MAZA-Shield-v1.0** | Risk Management Report | `docs/qmsr-iso13485/records/risk-management/Risk-Management-Report-MAZA-Shield-v1.0.md` | Executive risk posture summary |
| **VP-MAZA-Shield-v1.0** | Verification Plan | `docs/qmsr-iso13485/plans/VP-MAZA-Shield-v1.0.md` | Design verification strategy |
| **VALP-MAZA-Shield-v1.0** | Validation Plan | `docs/qmsr-iso13485/plans/VALP-MAZA-Shield-v1.0.md` | Intended-use validation strategy (**VL-xxx**) |
| **RR-MAZA-Shield-v1.0** | Release Record | `docs/qmsr-iso13485/records/release-records/RR-MAZA-Shield-v1.0.md` | Release criteria, residual risk acceptance, authorization posture |
| **QMSR-Master-Index-MAZA-Shield-v1.0** | QMSR Master Index | `docs/qmsr-iso13485/QMSR-Master-Index-MAZA-Shield-v1.0.md` | Complete document register |

Supporting context **non-substitutive** for controlled packages: `docs/PROJECT_CONTEXT.md` (technical narrative).

## 4. Key Discussion Points

| Topic | Management observations |
|-------|-------------------------|
| **Design controls closure** | Design inputs (**DID**) were formally reviewed under **DR-MAZA-001**; design outputs (**DOS**) describe architecture and interfaces consistent with the declared baseline. Trace scaffolding toward atomic matrices remains a sustaining activity per DR action items; management accepts continuation under Quality ownership without blocking v1.0 readiness contingent on evidence disposition elsewhere. |
| **Risk posture** | **RMF** and **Risk Management Report** identify high-RPN themes (**RM-008, RM-010, RM-017, RM-019**, etc.) with documented controls and residual-risk narratives. Management reaffirms **human-in-the-loop** and jurisdictional operator accountability (**RM-013**, statutory partitions). |
| **Verification & validation** | **VP** and **VALP** define repeatable verification vs validation boundaries (“built correctly” vs “right product”). Management expects objective verification evidence and validation summaries (e.g., VSR) to be filed per plans prior to or concurrent with release authorization referenced in **RR**. |
| **Release readiness** | **RR** consolidates release criteria (**RC-xxx**), evidence pointers, and residual-risk acceptance. Management treats RR completion (including signatures and configuration baseline identifier) as the formal gate for endorsing commercialization of the MAZA Shield v1.0 software baseline within documented scope exclusions. |
| **Document control & audit trail** | **QMSR Master Index** provides audit navigation across MAZA Shield v1.0 controlled documents; management directs maintenance of the index upon superseding revisions. |
| **Improvement & surveillance** | Post-release monitoring, CAPA interfaces, and periodic risk review cadence align with **DP** and **RMF** surveillance clauses; feedback from validation exercises (including conference rehearsal where applicable) feeds backlog and risk register. |

## 5. Decisions & Action Items

### 5.1 Decisions

| Decision ID | Decision |
|-------------|----------|
| **DEC-MR-MS01** | Management **accepts** the MAZA Shield v1.0 QMSR artifact package enumerated in Section 3 as the **current controlled baseline** for design controls, risk management, and V&V planning, subject to closure of open action items and RR authorization steps. |
| **DEC-MR-MS02** | **Residual risks** documented in **RMF** / **RR** remain **conditionally accepted** only where controls, labeling, and operator accountability measures remain in force; any relaxation requires formal change control and revised risk acceptance. |
| **DEC-MR-MS03** | **Atomic trace matrices** (**UN/SR ↔ verification evidence ↔ RM**) shall remain under Quality custody with periodic reconciliation to implementation tags; spreadsheet/tool location referenced from Quality records. |

### 5.2 Action items

| AI ID | Description | Owner | Target date | Status |
|-------|-------------|-------|-------------|--------|
| **AI-MR-MS01** | Close **RR-MAZA-Shield-v1.0** signatures and record **release baseline identifier** (tag/commit/build) when verification/validation evidence disposition satisfies RC checklist | Product Owner / Quality | May 15, 2026 | Open |
| **AI-MR-MS02** | Publish consolidated **requirements ↔ verification ↔ risk** mapping revision per **DR-MAZA-001** sustaining actions | Quality / Regulatory | May 15, 2026 | Open |
| **AI-MR-MS03** | Confirm **SR-P-001** (latency) benchmark capture against documented hardware profile where cited as gating evidence | Lead Engineer | May 15, 2026 | Open |
| **AI-MR-MS04** | Schedule **next management review** or interim risk review after first significant post-release change cluster or within regulatory cadence | Management | Q3 2026 | Open |

## 6. Overall Conclusions

Management concludes that the **MAZA Shield v1.0** quality planning and design-control artifacts (**DP, DID, DOS, DR**), **risk management** documentation (**RMF**, **Risk Management Report**), **verification and validation** plans (**VP**, **VALP**), **release** framework (**RR**), and **document register** (**QMSR Master Index**) constitute an **auditable, coherent package** consistent with MAZALab’s stated Casino Risk Intelligence intended use and ISO 13485–oriented discipline.

**No systemic inadequacy** of the quality management system elements reviewed was identified that would preclude progression toward formal release authorization, **provided** open action items are executed, verification and validation evidence is filed per agreed plans, and **RR** authorization is completed.

## 7. Approval

This Management Review Record was conducted with management participation appropriate to MAZALab procedure. Signatures attest that inputs were reviewed and conclusions accepted.

| Role | Name | Signature | Date |
|------|------|-----------|------|
| Prepared by | Laura (MAZALab) | | April 28, 2026 |
| Management (authorized representative) | | | April 28, 2026 |
| Quality / Regulatory (optional witness) | | | April 28, 2026 |

**Distribution:** Controlled copy — Quality records; Management file.
